Skip to main content
SpringerLink
Log in

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling

  • Original Research
  • Published:
Journal of Genetic Counseling

Abstract

Telephone genetic counseling (TC) for hereditary breast/ovarian cancer risk has been associated with positive outcomes in high risk women. However, little is known about how patients perceive TC. As part of a randomized trial of TC versus usual care (UC; in-person genetic counseling), we compared high risk women’s perceptions of: (1) overall satisfaction with genetic counseling; (2) convenience; (3) attentiveness during the session; (4) counselor effectiveness in providing support; and (5) counselor ability to recognize emotional responses during the session. Among the 554 participants (TC, N = 272; UC, N = 282), delivery mode was not associated with self-reported satisfaction. However, TC participants found counseling significantly more convenient than UC participants (OR = 4.78, 95 % CI = 3.32, 6.89) while also perceiving lower levels of support (OR = 0.56, 95 % CI = 0.40–0.80) and emotional recognition (OR = 0.53, 95 % CI = 0.37–0.76). In exploratory analyses, we found that non-Hispanic white participants reported higher counselor support in UC than in TC (69.4 % vs. 52.8 %; OR = 3.06, 95 % CI = 1.39–6.74), while minority women perceived less support in UC vs. TC (58.3 % vs. 38.7 %; OR = 0.80, 95 % CI = 0.39–1.65). We discuss potential research and practice implications of these findings which may further improve the effectiveness and utilization of TC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Adams, I., Christopher, J., Williams, K. P., & Sheppard, V. B. (2015). What black women know and want to know about counseling and testing for BRCA1/2. Journal of Cancer Education, 30(2), 344–352.

    Article  PubMed  Google Scholar 

  • Baumanis, L., Evans, J. P., Callanan, N., & Susswein, L. R. (2009). Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction. Journal of Genetic Counseling, 18(5), 447–463.

    Article  CAS  PubMed  Google Scholar 

  • Bellcross, C. A., Kolor, K., Goddard, K. A., Coates, R. J., Reyes, M., & Khoury, M. J. (2011). Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. American Journal of Preventive Medicine, 40(1), 61–66.

    Article  PubMed  Google Scholar 

  • Berry, D. A., Iversen, E. S., Jr., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., et al. (2002). BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Journal of Clinical Oncology, 20(11), 2701–2712.

    Article  CAS  PubMed  Google Scholar 

  • Biesecker, B. B., Erby, L. H., Woolford, S., Adcock, J. Y., Cohen, J. S., Lamb, A., et al. (2013). Development and validation of the psychological adaptation scale (PAS): use in six studies of adaptation to a health condition or risk. Patient Education and Counseling, 93(2), 248–254.

    Article  PubMed  Google Scholar 

  • Blair, I. V., Steiner, J. F., Fairclough, D. L., Hanratty, R., Price, D. W., Hirsh, H. K., et al. (2013). Clinicians’ implicit ethnic/racial bias and perceptions of care among black and Latino patients. Annals of Family Medicine, 11(1), 43–52.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bradbury, A. R., Patrick-Miller, L., Fetzer, D., Egleston, B., Cummings, S. A., Forman, A., et al. (2011). Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clinical Genetics, 79(2), 125–131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bradbury, A. R., Patrick-Miller, L., Long, J., Powers, J., Stopfer, J., Forman, A., et al. (2015). Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genetics in Medicine, 17(6), 485–492.

    Article  PubMed  Google Scholar 

  • Busija, L., Pausenberger, E., Haines, T. P., Haymes, S., Buchbinder, R., & Osborne, R. H. (2011). Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care & Research (Hoboken), 63 Suppl 11 S383-S412.

  • Butrick, M., Kelly, S., Peshkin, B. N., Luta, G., Nusbaum, R., Hooker, G. W., et al. (2015). Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genetics in Medicine, 17(6), 467–475.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385–396.

    Article  CAS  PubMed  Google Scholar 

  • Cooper, L. A., Roter, D. L., Carson, K. A., Beach, M. C., Sabin, J. A., Greenwald, A. G., et al. (2012). The associations of clinicians’ implicit attitudes about race with medical visit communication and patient ratings of interpersonal care. American Journal of Public Health, 102(5), 979–987.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cragun, D., Camperlengo, L., Robinson, E., Caldwell, M., Kim, J., Phelan, C., et al. (2015). Differences in BRCA counseling and testing practices based on ordering provider type. Genetics in Medicine, 17(1), 51–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cukier, Y. R., Thompson, H. S., Sussner, K., Forman, A., Jandorf, L., Edwards, T., Bovbjerg, D. H., Schwartz, M. D., & Valdimarsdottir, H. B. (2013). Factors associated with psychological distress among women of African descent at high risk for BRCA mutations. Journal of Genetic Counseling, 22(1), 101–107.

    Article  PubMed  Google Scholar 

  • DeMarco, T. A., Peshkin, B. N., Mars, B. D., & Tercyak, K. P. (2004). Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. Journal of Genetic Counseling, 13(4), 293–304.

    Article  PubMed  PubMed Central  Google Scholar 

  • Eijzenga, W., Aaronson, N. K., Hahn, D. E., Sidharta, G. N., van der Kolk, L. E., Velthuizen, M. E., et al. (2014). Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. Journal of Clinical Oncology, 32(27), 2998–3004.

    Article  PubMed  Google Scholar 

  • Elliott, A. M., Chodirker, B. N., Bocangel, P., & Mhanni, A. A. (2014). Evaluation of a clinical genetics service--a quality initiative. Journal of Genetic Counseling, 23(5), 881–889.

    Article  PubMed  Google Scholar 

  • Erblich, J., Brown, K., Kim, Y., Valdimarsdottir, H. B., Livingston, B. E., & Bovbjerg, D. H. (2005). Development and validation of a breast cancer genetic counseling knowledge questionnaire. Patient Education and Counseling, 56(2), 182–191.

    Article  PubMed  Google Scholar 

  • Fehniger, J., Lin, F., Beattie, M. S., Joseph, G., & Kaplan, C. (2013). Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. Journal of Genetic Counseling, 22(5), 603–612.

    Article  PubMed  Google Scholar 

  • Forman, A. D., & Hall, M. J. (2009). Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. The Breast Journal, 15(Suppl 1), S56–S62.

    Article  PubMed  Google Scholar 

  • Genome Web. (2013). InformedDNA to provide genetic counseling for Cigna members. Retrieved June 16, 2015, from https://www.genomeweb.com/clinical-genomics/informeddna-provide-genetic-counseling-cigna-members.

  • Halbert, C. H., Kessler, L., Collier, A., Weathers, B., Stopfer, J., Domchek, S., et al. (2012). Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? Journal of Genetic Counseling, 21(5), 676–683.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., et al. (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer, 115(10), 2222–2233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: a measure of subjective stress. Psychosomatic Medicine, 41(3), 209–218.

    Article  CAS  PubMed  Google Scholar 

  • Kelly, K. M., Ellington, L., Schoenberg, N., Agarwal, P., Jackson, T., Dickinson, S., et al. (2014). Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk. Journal of Genetic Counseling, 23(5), 838–848.

    Article  PubMed  PubMed Central  Google Scholar 

  • King, M. C., Levy-Lahad, E., & Lahad, A. (2014). Population-based screening for BRCA1 and BRCA2: 2014 Lasker award. JAMA, 312(11), 1091–1092.

    Article  CAS  PubMed  Google Scholar 

  • Kinney, A. Y., Butler, K. M., Schwartz, M. D., Mandelblatt, J. S., Boucher, K. M., Pappas, L. M., et al. (2014). Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Journal of the National Cancer Institute, 106(12), pii: dju328. doi: 10.1093/jnci/dju328.

  • Levine, C. S., & Ambady, N. (2013). The role of non-verbal behaviour in racial disparities in health care: implications and solutions. Medical Education, 47(9), 867–876.

    Article  PubMed  Google Scholar 

  • Levy, D. E., Byfield, S. D., Comstock, C. B., Garber, J. E., Syngal, S., Crown, W. H., et al. (2011). Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genetics in Medicine, 13(4), 349–355.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lynch, H. T., Snyder, C., Stacey, M., Olson, B., Peterson, S. K., Buxbaum, S., et al. (2014). Communication and technology in genetic counseling for familial cancer. Clinical Genetics, 85(3), 213–222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Madlensky, L. (2014). Is it time to embrace telephone genetic counseling in the oncology setting? Journal of Clinical Oncology, 32(7), 611–612.

    Article  PubMed  Google Scholar 

  • Mai, P. L., Vadaparampil, S. T., Breen, N., McNeel, T. S., Wideroff, L., & Graubard, B. I. (2014). Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 national health interview surveys. American Journal of Preventive Medicine, 46(5), 440–448.

    Article  PubMed  PubMed Central  Google Scholar 

  • McAllister, M., & Dearing, A. (2015). Patient reported outcomes and patient empowerment in clinical genetics services. Clinical Genetics, 88(2), 114–121.

    Article  CAS  PubMed  Google Scholar 

  • McDonald, E., Lamb, A., Grillo, B., Lucas, L., & Miesfeldt, S. (2014). Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings. Journal of Genetic Counseling, 23(2), 221–228.

    Article  PubMed  Google Scholar 

  • National Comprehensive Cancer Network. (2015). NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.2.2015. Retrieved September 8, 2015, from http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.

  • National Society of Genetic Counselors. (2014a). 2014 Professional Status Survey: Executive Summary. Retrived May 12, 2015, from http://nsgc.org/p/cm/ld/fid=68.

  • National Society of Genetic Counselors. (2014b). 2014 Professional Status Survey: Work Environment. Retrieved May 12, 2015, from http://nsgc.org/p/do/sd/sid=2478&type=0.

  • O’Connor, A. M. (1993). User Manual-Decisional Conflict Scale (10-item question format). Ottawa, ON, Canada, Ottawa Hospital Research Institute, 1993 (updated 2010). Retrieved May 12, 2015, from http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf.

  • Patrick-Miller, L. J., Egleston, B. L., Fetzer, D., Forman, A., Bealin, L., Rybak, C., et al. (2014). Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition. JMIR Research Protocols, 3(4), e49.

    Article  PubMed  PubMed Central  Google Scholar 

  • Peshkin, B. N., DeMarco, T. A., Graves, K. D., Brown, K., Nusbaum, R. H., Moglia, D., et al. (2008). Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genetic Testing, 12(1), 37–52.

    Article  PubMed  Google Scholar 

  • Schaa, K. L., Roter, D. L., Biesecker, B. B., Cooper, L. A., & Erby, L. H. (2015). Genetic counselors’ implicit racial attitudes and their relationship to communication. Health Psychology, 34(2), 111–119.

    Article  PubMed  Google Scholar 

  • Schwartz, L. M., Woolshin, S., Black, W. C., & Welch, H. G. (1997). The role of numeracy in understanding the benefit of screening mammography. Annals of Internal Medicine, 127(11), 966–972.

    Article  CAS  PubMed  Google Scholar 

  • Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Halbert, C. H., DeMarco, T., et al. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology, 22(10), 1823–1829.

    Article  PubMed  Google Scholar 

  • Schwartz, M. D., Valdimarsdottir, H. B., Peshkin, B. N., Mandelblatt, J., Nusbaum, R., Huang, A. T., et al. (2014). Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. Journal of Clinical Oncology, 32(7), 618–626.

    Article  PubMed  PubMed Central  Google Scholar 

  • Society of Gynecologic Oncology. (2014). SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer, October 2014. Retrieved May 12, 2015, from https://www.sgo.org/clinical-practice/guidelines/genetic-testing-for-ovarian-cancer/.

  • Sussner, K. M., Edwards, T. A., Thompson, H. S., Jandorf, L., Kwate, N. O., Forman, A., et al. (2011). Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics, 14(6), 356–370.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sussner, K. M., Jandorf, L., Thompson, H. S., & Valdimarsdottir, H. B. (2013). Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psycho-Oncology, 22(7), 1594–1604.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sussner, K. M., Edwards, T., Villagra, C., Rodriguez, M. C., Thompson, H. S., Jandorf, L., et al. (2015). BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation. Journal of Genetic Counseling, 24(1), 134–148.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sutphen, R., Davila, B., Shappell, H., Holtje, T., Vadaparampil, S., Friedman, S., et al. (2010). Real world experience with cancer genetic counseling via telephone. Familial Cancer, 9(4), 681–689.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K., et al. (2015). Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer, 121(1), 25–33.

    Article  CAS  PubMed  Google Scholar 

  • U.S.Preventive Services Task Force. (2013). Recommendation Summary. BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing. December 2013. Retrived May 12, 2015, from http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing.

  • University of Texas Southwestern Medical Center at Dallas. (2015). CancerGene. Retrieved May 12, 2015, from http://www.utsouthwestern.edu/education/medical-school/departments/surgery/divisions/surgical-oncology/research/cancergene/index.html.

  • Vadaparampil, S. T., Quinn, G. P., Small, B. J., McIntyre, J., Loi, C. A., Closser, Z., et al. (2010). A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer. Genetic Testing and Molecular Biomarkers, 14(1), 99–106.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vadaparampil, S. T., Scherr, C. L., Cragun, D., Malo, T. L., & Pal, T. (2015). Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida. Clinical Genetics, 87(5), 473–477.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.

    Article  PubMed  Google Scholar 

  • Wham, D., Vu, T., Chan-Smutko, G., Kobelka, C., Urbauer, D., & Heald, B. (2010). Assessment of clinical practices among cancer genetic counselors. Familial Cancer, 9(3), 459–468.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge contributions of genetic counselors Karen Brown, Diana Moglia Tully, Alexandra Lebensohn, and Emily Dalton. In addition, we thank our research assistants for performing telephone interviews: Elizabeth Poggi, Kara-Grace Leventhal, Lisa Moss, Sarah Kelleher, Patty Vegella, Angie Tong, Lesley King, Lisa Feeley, Lauren Vanhusen, Kathy Corso, and Liz Zeida. We also thank Susan Marx and Aryana Jacobs for assistance with manuscript preparation. Finally, we are grateful to all of the women who participated in the study.

Funding

The study was supported by Grants R01 CA108933 and P30 CA051008 from the National Cancer Institute and by the Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Conflict of Interest

Ms. Peshkin, Mr. Kelly, Ms. Similuk, Ms. DeMarco, Dr. Valdimarsdottir, Ms. Forman, Ms. Rispoli Joines, Ms. Davis, Ms. McKinnon, Dr. Graves, Dr. Isaacs, Dr. Wood, and Ms. Jandorf declare that they have no conflict of interest. Ms. Nusbaum is an employee of GeneDx, but was employed at Georgetown University during all patient accrual and data collection. Dr. Hooker is an employee of NextGxDx, but was employed at Georgetown University during her participation in the study. Ms. McCormick has obtained paid compensation from Myriad Genetics. Dr. Garber has research funding from Myriad Genetics. Dr. Schwartz serves as an uncompensated member of the Scientific Advisory Board for InformedDNA (St. Petersburg, FL).

Human Studies and Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible institutional review committees of the collaborating institutions, national guidelines, and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all individual participants included in the study.

Animal Studies

No animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

  1. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA

    Beth N. Peshkin, Kristi D. Graves, Claudine Isaacs & Marc D. Schwartz

  2. Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, 20007, USA

    Beth N. Peshkin, Kristi D. Graves, Claudine Isaacs & Marc D. Schwartz

  3. Department of Epidemiology and Biostatistics, George Washington University, Washington, DC, USA

    Scott Kelly

  4. GeneDx, Gaithersburg, MD, USA

    Rachel H. Nusbaum

  5. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    Morgan Similuk

  6. Cancer Genetic Counseling Program, Inova Translational Medicine Institute, Inova Health System, Falls Church, VA, USA

    Tiffani A. DeMarco

  7. NextGxDx, Inc, Franklin, TN, USA

    Gillian W. Hooker

  8. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Heiddis B. Valdimarsdottir & Lina Jandorf

  9. Department of Psychology, Reyjavik University, Reyjavik, Iceland

    Heiddis B. Valdimarsdottir

  10. Department of Clinical Genetics, Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, PA, USA

    Andrea D. Forman

  11. Department of Medicine, Division of Hematology/Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA

    Jessica Rispoli Joines

  12. Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College, Yonkers, NY, USA

    Claire Davis

  13. Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Shelley R. McCormick & Judy Garber

  14. Familial Cancer Program, University of Vermont Cancer Center, Burlington, VT, USA

    Wendy McKinnon & Marie Wood

Authors
  1. Beth N. Peshkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rachel H. Nusbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Morgan Similuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tiffani A. DeMarco
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gillian W. Hooker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heiddis B. Valdimarsdottir
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrea D. Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jessica Rispoli Joines
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Claire Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shelley R. McCormick
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Wendy McKinnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Kristi D. Graves
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Claudine Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Judy Garber
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Marie Wood
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Lina Jandorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Marc D. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beth N. Peshkin.

Additional information

ClinicalTrials.gov Identifier: NCT00287898

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peshkin, B.N., Kelly, S., Nusbaum, R.H. et al. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling. J Genet Counsel 25, 472–482 (2016). https://doi.org/10.1007/s10897-015-9897-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-015-9897-6

Keywords

Search

Navigation